Skip to content
+1 416-961-JOIN (5646)info@JoinAStudy.ca+1 416-961-JOIN (5646)
Facebook page opens in new windowX page opens in new windowInstagram page opens in new windowYouTube page opens in new window
Facebook page opens in new windowX page opens in new windowInstagram page opens in new windowYouTube page opens in new window
JoinAStudy.ca
JoinAStudy.ca
JoinAStudy.ca – Help create a healthier future
JoinAStudy.caJoinAStudy.ca
  • Home
  • Current Studies
  • Medical Conditions
  • Study Locations
  • Health Blog
  • Why JoinAStudy?
Search:
info@JoinAStudy.ca
Search:
Search:
JoinAStudy.ca JoinAStudy.ca JoinAStudy.caJoinAStudy.ca
  • Home
  • Current Studies
  • Medical Conditions
  • Study Locations
  • Health Blog
  • Why JoinAStudy?
+1 416-961-JOIN (5646)info@JoinAStudy.ca
Facebook page opens in new windowX page opens in new windowInstagram page opens in new windowYouTube page opens in new window

Daily Archives: <span>March 30, 2021</span>

You are here:
  1. Home
  2. March 2021

obesity, diabetes

Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk

Heart Health, Drug Development, Study ResultsBy JoinAStudy TeamMarch 30, 2021

A round of applause for our research site physicians Dr Sam Henein and Dr Michael O’Mahony for their participation in the Amarin REDUCE-IT hypertriglyceridemia study!

© Copyright - JoinAStudy.ca, 2018. All rights reserved
Designed by Pixelore.ca

JoinAStudy.ca does not provide medical advice, diagnosis or treatment.

Information Disclaimer | Privacy | Contact Us

Go to Top
  • English
  • Français